Grants and Contracts Details
Description
SPECIFIC AIMS
Patients with diabetes are -3 times more likely to develop heart failure than patients who are
not diabetic [5]. The earliest clinical sign of ventricular problems in human patients is left-
ventricular diastolic dysfunction. This condition is characterized by slowed ventricular
relaxation and increased myocardial stiffness and leads to a situation in which the ventricles do
not fill properly with blood between contractions. The clinical dysfunction probably reflects
changes in both the "active" (myosin-based) and "passive" (collagen, elastin and titin-based)
molecular components of ventricular stiffness [38].
Clinical and epidemiological findings [27, 28, 31] show that the hearts of male and female
patients respond differently during diabetes. Men with diabetes are twice as likely to develop
heart failure than men without diabetes while diabetic women are five times more likely to
develop heart failure than their non-diabetic controls [16]. The molecular mechanisms
underlying the different disease progressions in men and women are currently unclear.
The research proposed in this application will analyze a standard animal model of Type I
diabetes (streptozotocin-injected rats) to provide new information about the development of
diastolic dysfunction in males and females. Clinicians and scientists will be able to use this
information to develop better treatment strategies for men and women with diabetes.
Status | Finished |
---|---|
Effective start/end date | 7/1/09 → 6/30/11 |
Funding
- American Heart Association Great Rivers Affiliate: $88,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.